MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature

MOGAD Involving Cranial Neuropathies: A Case Report and Review of Literature

Myelin-oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an autoimmune-mediated demyelinating disease of the central nervous system (CNS). Patients with MOGAD may develop any combination of optic neuritis (ON), myelitis, brainstem syndrome and encephalitis. Reports of MOGAD w...

Full description

Bibliographic Details
Main Authors:	Yangsa Du, Ling Xiao, Zijin Ding, Kailing Huang, Bo Xiao, Li Feng
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Brain Sciences
Subjects:	myelin oligodendrocyte glycoprotein MOGAD anti-MOG cranial neuropathies optic neuritis
Online Access:	https://www.mdpi.com/2076-3425/12/11/1529

Similar Items

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01)

Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?
by: Joachim Havla, et al.
Published: (2021-05-01)

The diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children
by: Ünsal Yılmaz
Published: (2024-02-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
by: Yohane Gadama, et al.
Published: (2023-10-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
by: Wojciech Ambrosius, et al.
Published: (2020-12-01)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
by: Osman Corbali, et al.
Published: (2023-02-01)

A Rare Case Report: MOGAD with Optic Neuritis- without Spinal İnvolvement
by: Canan Akünal Türel, et al.
Published: (2023-04-01)

High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting
by: Tammy L. Smith, et al.
Published: (2023-07-01)

Clinical Features and Imaging Findings of Myelin Oligodendrocyte Glycoprotein-IgG-Associated Disorder (MOGAD)
by: Yunjie Li, et al.
Published: (2022-03-01)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
by: Sven Jarius, et al.
Published: (2020-09-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
by: Leilei Mao, et al.
Published: (2019-08-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
by: Sven Jarius, et al.
Published: (2020-09-01)

A case report of neurosyphilis coexisting with a positive MOG antibody manifested as optic neuritis
by: Min Shi, et al.
Published: (2023-09-01)

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases
by: Patrick Peschl, et al.
Published: (2017-05-01)

The difference of the retinal structural and microvascular characteristics in patients with MOGAD-ON and AQP4-ON
by: Yajun Yao, et al.
Published: (2022-08-01)

Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications
by: Nithisha Thatikonda, et al.
Published: (2020-04-01)

The MOG antibody associated encephalitis preceded by COVID-19 infection; a case study and systematic review of the literature
by: Michał Borończyk, et al.
Published: (2023-08-01)

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
by: Maria Schroeder-Castagno, et al.
Published: (2022-10-01)

Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder
by: Yunjie Li, et al.
Published: (2022-09-01)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
by: Sara Mariotto, et al.
Published: (2017-10-01)

Anti-MOG Antibody-Associated Unilateral Cortical Encephalitis with Bilateral Meningeal Involvement: A Case Report
by: Bo Ren, et al.
Published: (2023-02-01)

Myelitis features and outcomes in CNS demyelinating disorders: Comparison between multiple sclerosis, MOGAD, and AQP4-IgG-positive NMOSD
by: Giulia Fadda, et al.
Published: (2022-11-01)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
by: Erica Parrotta, et al.
Published: (2020-09-01)

Pattern Visually Evoked Potentials in Japanese Girl With Optic Neuritis and Seropositive to Anti-myelin Oligodendrocyte Glycoprotein (MOG) Antibody
by: Shunichiro Takano, et al.
Published: (2019-12-01)

Clinical, radiological, therapeutic and prognostic differences between MOG-seropositive and MOG-seronegative pediatric acute disseminated encephalomyelitis patients: a retrospective cohort study
by: Xueshan Dong, et al.
Published: (2023-05-01)

Neuritis optica bilateral asociado anticuerpos anti-glicoproteina de la mielina del oligodendrocito (MOGAD): Reporte de caso
by: Karelys Moreno Arias, et al.
Published: (2023-12-01)

Neuritis optica bilateral asociado anticuerpos anti-glicoproteina de la mielina del oligodendrocito (MOGAD): Reporte de caso
by: Karelys Moreno Arias, et al.
Published: (2023-12-01)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
by: Giovanna S. Manzano, et al.
Published: (2022-06-01)

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD)
by: Satomi Hiya, et al.
Published: (2023-06-01)

Leber’s hereditary optic neuropathy companied with multiple-related diseases
by: Ming-ming Sun, et al.
Published: (2022-11-01)

A rare presentation of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) as acute hemorrhagic longitudinally extensive transverse myelitis
by: Aniket Nerlekar, et al.
Published: (2023-11-01)

Recurrent myelin oligodendrocyte glycoprotein⁃IgG⁃associated optic neuritis⁃encephalomyelitis: one case report
by: Jing SHA, et al.
Published: (2020-10-01)

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
by: Frederike C. Oertel, et al.
Published: (2019-07-01)

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
by: Masoud Etemadifar, et al.
Published: (2017-10-01)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
by: Haeng-Jin Lee, et al.
Published: (2018-10-01)

Optomyelitis associated with the presence of antibodies to myelin oligodendrocyte glycoprotein. Case report
by: Anastasiia K. Kalashnikova, et al.
Published: (2022-02-01)

Serial analyses of clinical spectra and outcomes in Chinese women with pregnancy-induced optic neuritis
by: Wenhao Bai, et al.
Published: (2022-11-01)

The establishment and application of MOG-IgG-mediated complement-dependent in vitro demyelination model
by: Chen Yashuang, Xiao Xiuqing, Wang Shisi, Mo Yongxin, Sun Xiaobo, Zhong Xiaofen, Peng Lisheng
Published: (2022-03-01)